Skip to product information
RJVA-RT30 30mg (GLP-3 RT)
$120.00 USD
A 39-amino acid triple agonist peptide targeting GIP, GLP-1, and glucagon receptors, studied for metabolic regulation and body composition in clinical research.
An investigational triple‑agonist peptide being studied for weight loss, obesity‑related conditions, type 2 diabetes, and metabolic disorders